Skip to main content
v2026.11,610 entries · CC-BY 4.0

Infusion Supplies and Pump Selection: A Buying Guide for Clinical Settings

A buying guide for clinical procurement teams and home-care buyers: how to choose between volumetric, syringe, and ambulatory infusion pumps, why free-flow protection matters, and what extension-set/tubing compatibility to check before standardizing a formulary.

Ask about Infusion Supplies and Pump Selection: A Buying Guide for Clinical Settings

Answers are drawn from this guide and the rest of the CASRAI corpus, with a link to every source.

Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this

Written and maintained by CASRAI Editorial Board

Last updated

Standardizing an infusion formulary means choosing a pump platform and a matching set of administration sets, extension sets, and accessories that a hospital, clinic, or EMS service will buy and service by the case — or, for an individual managing home infusion therapy, choosing the single device and supply set that has to work reliably without a biomedical engineering department down the hall. Both buyers are making the same underlying decision: which pump technology fits the therapy, and which supplies are actually compatible with it. This guide covers the three pump categories in real clinical use, free-flow protection as a documented safety requirement rather than a marketing checkbox, and the extension-set and tubing compatibility questions that determine whether a formulary standardization actually holds up in practice.

Volumetric vs. Syringe vs. Ambulatory: Matching Pump Type to Use Case

“Infusion pump” covers three mechanically distinct device families, and the wrong one for the therapy is a safety problem, not just an inefficiency.

  • Volumetric (large-volume) pumps use a peristaltic mechanism — computer-controlled rollers or sequential fingers compressing a section of tubing — to deliver larger volumes at a programmed rate. This is the default platform for IV fluids, antibiotics, blood products (where the pump is rated for it), and general-ward continuous infusions. Most current-generation volumetric pumps ship with dose-error-reduction software (DERS) — a “smart pump” drug library with hospital-configured hard and soft dosing limits — which is now the de facto standard of care in acute settings, not an optional add-on.
  • Syringe pumps use a computer-controlled motor driving a syringe plunger at a precisely controlled rate, which makes them the right choice for low-volume, high-precision infusions where a peristaltic pump’s flow variability matters clinically: vasoactive drips (norepinephrine, vasopressin), neonatal and pediatric dosing, insulin, and other continuous infusions delivered in mL/hr fractions rather than whole units. Syringe size and brand matter here in a way they don’t for volumetric pumps — most syringe pumps are only accuracy-validated against a specific, limited list of syringe manufacturers and sizes, which is itself a formulary decision (see below).
  • Ambulatory and elastomeric pumps serve outpatient and home infusion: patient-controlled analgesia, outpatient chemotherapy, and home IV antibiotic therapy. Battery-powered ambulatory pumps retain programmability and alarms in a portable form factor; elastomeric (“balloon”) pumps use the gradual contraction of a pre-filled elastomeric reservoir to deliver a fixed or roughly fixed rate with no electricity, no battery, and no programming — which is exactly the trade-off that makes them appropriate for home use and inappropriate for anything requiring a titratable, precisely controlled rate.
Pump type Typical setting Precision / control Portability
Volumetric (peristaltic) ICU, med-surg, ED, infusion centers High; programmable rate/VTBI, smart-pump drug library Pole-mounted, mains + battery backup
Syringe ICU/NICU vasoactive and low-volume drips, insulin Highest at low flow rates (mL/hr and below) Pole/rail-mounted, battery backup
Ambulatory (battery) PCA, outpatient chemo, home IV antibiotics Moderate-high; programmable, patient-portable Fully portable, belt/bag-carried
Elastomeric (non-electric) Home infusion, single fixed-rate courses Fixed or narrow-range rate only; no alarms Fully portable, disposable

Free-Flow Protection: A Real Safety Requirement, Not a Nice-to-Have

Free flow is the uncontrolled, gravity-driven delivery of IV fluid or medication when tubing is removed from a pump — or loaded into one — without the clamp engaged. Because peristaltic and syringe pumps only control flow while the tubing is actively seated in the mechanism, a set that lacks its own anti-free-flow protection can deliver an unrestricted bolus the moment it’s opened for line changes, transport, or troubleshooting, with no pump alarm to catch it because the pump isn’t in the circuit at that moment. This is not a theoretical failure mode: FDA’s Infusion Pump Improvement Initiative, launched in 2010 after the agency received roughly 56,000 adverse-event reports tied to infusion pumps between 2005 and 2009 — including injuries and deaths — identified software defects, user-interface design, and mechanical/electrical failures as the recurring device-side contributors, and free-flow events are among the harms that pattern produces.

Protection against free flow is built two ways, and a formulary should specify both rather than relying on either alone:

  • Pump-integrated protection — a mechanical occluder built into the pump’s door or mechanism that pinches the tubing closed automatically whenever the set is removed, independent of any action by the clinician.
  • Set-integrated protection — an anti-free-flow valve or clamp molded into the administration set itself, which closes when the set is out of the pump regardless of which pump (or none) it’s loaded into. This matters specifically when a set gets used with a gravity setup or a different pump model than the one it was validated against.

ANSI/AAMI/IEC 60601-2-24, the particular (device-specific) safety standard covering infusion pumps and controllers, is the standard most commonly cited by manufacturers and biomedical engineering staff for essential-performance requirements in this space, free-flow behavior included — ask any pump vendor for their conformance documentation against it rather than taking a “free-flow protected” label at face value. When standardizing a formulary, confirm the specific administration sets you intend to stock are validated by the pump manufacturer for anti-free-flow performance on that pump model — a generic or off-formulary set may fit the mechanism physically without carrying the same free-flow protection the pump manufacturer tested.

Extension Sets and Tubing: What “Compatible” Actually Means

Standardizing a formulary around one pump platform only works if the extension sets, primary tubing, and accessories bought alongside it are actually compatible in every dimension that matters — not just “the connector fits.”

  • Connector family. Standard IV extension sets use Luer connectors, now formalized as ISO 80369-7 for intravascular and hypodermic applications. The broader ISO 80369 small-bore connector series exists specifically because of documented tubing misconnections between clinically distinct systems — most notably IV lines connected to epidural/neuraxial lines or enteral feeding lines, sometimes fatally. ISO 80369-6 (marketed as NRFit) covers neuraxial/regional-anesthesia connectors and ISO 80369-3 (ENFit) covers enteral feeding connectors; both are deliberately incompatible with Luer by design, so a feeding line or an epidural catheter physically cannot be connected to an IV extension set. When standardizing supplies across a facility, confirm every non-IV tubing family in use (enteral, neuraxial, respiratory) is actually on its own non-Luer connector standard — a legacy stock of Luer-compatible feeding sets is exactly the kind of gap a formulary review exists to catch.
  • Priming volume and dead space. Extension sets are commonly stocked in a range of lengths (short 7″–10″ sets up to long 30″–60″ sets) with proportionally different priming volumes, typically well under 5 mL for standard-bore sets and a fraction of a mL for true microbore sets. For neonatal, pediatric, and any low-volume high-potency infusion, priming volume is a dosing variable, not a logistics detail — a longer or wider-bore set than the therapy calls for delays how quickly a rate change actually reaches the patient.
  • Bore size. Standard-bore extension sets suit routine fluids and most medications; microbore sets reduce dead space and priming volume for low-volume infusions but also reduce maximum flow rate and increase occlusion-alarm sensitivity to viscosity — not a drop-in substitute for standard bore on every therapy.
  • Needle-free connector compatibility. Confirm the extension set’s Y-sites and end connectors match the facility’s standardized needle-free connector (split-septum vs. mechanical valve) — mixing connector types across a unit is a common source of both leakage and infection-control inconsistency.
  • Material. DEHP-free (non-PVC or DEHP-free PVC) tubing is now widely stocked as the default for neonatal, pediatric, and lipid/certain-drug infusions where DEHP leaching is a concern; confirm which product lines in a proposed formulary are DEHP-free versus standard, since both are usually still sold side by side.
  • Check valves and anti-siphon/back-check valves. For multi-line or multi-drug setups (a common ICU pattern), confirm the extension set includes an integrated check valve where the clinical protocol requires one — this prevents retrograde flow between simultaneously running infusions and is a standardization detail that’s easy to miss when consolidating vendors.

Standardizing a Formulary: Selection Criteria for Procurement Teams

For a clinical procurement or value-analysis team evaluating pump platforms at volume, the selection criteria extend well past unit price:

  • Drug library / DERS coverage and EHR interoperability. Confirm the pump’s smart-pump software supports the facility’s actual drug library size and update workflow, and — increasingly load-bearing — whether it supports bidirectional EHR/BCMA interoperability (auto-programming from the order, infusion data documented back to the chart) rather than one-way alarm logging only.
  • Occlusion alarm range and sensitivity. Pumps offer a configurable occlusion-pressure alarm range; the appropriate setting depends on catheter gauge, infusion viscosity, and set bore size — this is exactly why extension-set standardization and pump alarm configuration have to be decided together, not independently.
  • Battery life and charging infrastructure. For transport-heavy units (ED, imaging, inter-facility transfer), confirm battery runtime and the facility’s charging-station footprint before committing to a platform across those units.
  • Service, training burden, and vendor consolidation. A single validated pump-and-set platform reduces the number of distinct competency trainings staff need, reduces the odds of a mismatched off-formulary set reaching the bedside, and simplifies biomedical engineering’s preventive-maintenance and recall-tracking workload — see CASRAI’s medical equipment management plan guide for how that inventory and maintenance obligation gets documented for a Joint Commission survey.
  • Alignment with the medication formulary, not just the device formulary. Which pump and set combination is validated for which high-alert infusions (opioids, insulin, heparin, vasoactive agents) should be decided alongside — not after — the medication formulary process; see CASRAI’s hospital formulary management guide for how additions and removals move through P&T, and the high-alert medications guide for the safeguard layer each of those infusions needs beyond the pump itself.

Buying for Home or Personal Care

Individuals purchasing or renting infusion equipment for home use — most commonly for home IV antibiotic courses, outpatient pain management, or a home infusion therapy prescribed after a hospital stay — are making a narrower version of the same decision, usually guided by a home infusion pharmacy or DME supplier rather than a hospital value-analysis committee:

  • Elastomeric pumps are the simplest option for a single defined course: no programming, no battery to manage, no alarms to interpret — the trade-off is a fixed or narrow-range rate with no ability to adjust mid-course, so they suit therapies where the rate isn’t expected to change.
  • Battery-powered ambulatory pumps suit therapies needing a programmable or patient-controlled rate (PCA for pain management is the most common home use), and require more caregiver training — alarm response, battery management, and troubleshooting a occlusion or air-in-line alert without a nurse in the next room.
  • Supplies should match exactly what the home infusion provider specifies — connector type, extension-set length, and needle-free connector brand are not areas to substitute a “close enough” product, since a mismatch at home has no biomedical engineering safety net behind it. Confirm compatibility with the prescribing provider or home infusion pharmacy before purchasing replacement supplies independently.

Compliance and Safety Considerations When Standardizing

A formulary standardization project touches several compliance obligations at once, and it’s worth deciding the pump-and-set combination with these already in view rather than retrofitting them afterward:

  • Medical equipment inventory, maintenance-interval assignment, and incident investigation for the pumps themselves fall under Joint Commission standard EC.02.04.01 — see the medical equipment management plan guide for what that written plan has to specify.
  • ISMP’s smart-pump guidance and targeted medication safety best practices are the reference point most hospital medication-safety committees use when configuring drug libraries and dosing limits — see the ISMP targeted medication safety best practices guide for a self-assessment structure.
  • Peripheral IV insertion and line changes involve sharps and blood exposure risk covered by the facility’s bloodborne pathogens exposure control plan — see the exposure control plan for bloodborne pathogens guide for the required elements.

A Practical Selection Checklist

  • Does the pump category (volumetric, syringe, ambulatory, elastomeric) actually match the therapy’s precision and portability needs, not just what’s already on the shelf?
  • Does the pump have documented anti-free-flow protection, and does the extension set carry its own set-integrated protection validated against that specific pump model?
  • Are the extension sets on the correct connector standard for their clinical application (ISO 80369-7 Luer for IV; non-Luer ENFit/NRFit for enteral/neuraxial), with no legacy Luer-compatible stock left in a non-IV workflow?
  • Do priming volume and bore size fit the lowest-volume infusion this set will actually be used for, not just the average case?
  • Do the needle-free connectors on the extension set match the facility’s standardized connector, and are DEHP-free options stocked where the patient population requires them?
  • Does the pump’s drug library / DERS and EHR interoperability meet the unit’s actual workflow, and is occlusion-alarm range configured to match the set bore size in use?
  • For home/individual purchases: does every replacement supply match the exact connector, length, and brand the prescribing provider or home infusion pharmacy specified?

Where to Source Infusion Supplies and Pumps

CASRAI’s sister medical-supply business, LAC, stocks infusion pumps and the extension sets and administration supplies discussed in this guide, organized by category so you can compare options directly against the selection criteria above:

  • Infusion pumps — browse volumetric, syringe, and ambulatory pump listings.
  • IV extension sets — compare lengths, bore sizes, and connector configurations for formulary standardization.
  • Infusion supplies — the broader category for administration sets, needle-free connectors, and related accessories.

Frequently Asked Questions

What’s the difference between a volumetric pump and a syringe pump?
A volumetric pump uses a peristaltic mechanism to deliver larger-volume infusions at a programmed rate and is the default for general IV fluids and medications. A syringe pump drives a syringe plunger and delivers much smaller volumes with tighter precision, which is why it’s preferred for vasoactive drips, neonatal dosing, and other infusions measured in small mL/hr fractions.

Why does an IV extension set need its own free-flow protection if the pump already has it?
Pump-integrated protection only works while the set is loaded in that specific pump. A set that’s disconnected for transport, troubleshooting, or an equipment swap — or that ends up on a different pump model or a gravity setup — relies entirely on its own set-integrated anti-free-flow valve at that moment. Formularies that specify both layers close the gap either one leaves open alone.

Can a standard IV extension set be used for enteral feeding in a pinch?
No. IV (Luer, ISO 80369-7) and enteral feeding (ENFit, ISO 80369-3) connectors are intentionally built to different, incompatible small-bore standards specifically so the two systems cannot be cross-connected. Any workflow that still has Luer-compatible tubing anywhere in an enteral pathway is a misconnection risk that a supply standardization review should catch and eliminate.

Are elastomeric pumps appropriate for a therapy where the rate might need to change?
Generally no. Elastomeric pumps deliver at a fixed or narrow-range rate set by the device’s own reservoir design, with no programming and no alarms — they suit a single defined course at a stable rate, not a therapy where dose or rate is likely to be titrated.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →

Regulatory Radar

Stop finding out after the fact

$29/month, cancel anytime. Daily digest updates from our analysis, a dashboard holding the same items, and a cited assistant for everything they raise.

  • Federal Register, Federal Register+, Grants.gov, Regulations.gov, NSF News, UKRI, plus CASRAI’s own published content.
  • 44,322 indexed passages, and every answer cites the ones it drew on.